ArticleCureus2025
Cytomegalovirus-Associated Septic Shock Leading to Disseminated Intravascular Coagulation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cytomegalovirus (CMV) is typically asymptomatic in the immunocompetent but can cause deadly complications in the immunosuppressed. We report a rare case of a 58-year-old woman with stage IIIb chronic kidney disease, membranous glomerulonephritis, and diabetes mellitus who presented with profound weakness, watery diarrhea, and rectal bleeding. First managed for suspected infectious colitis, urinary tract infection, and acute kidney injury, she deteriorated quickly with confusion, hypotension, and fever. Severe metabolic acidosis, coagulopathy, and thrombocytopenia suggesting disseminated intravascular coagulation (DIC) were noted in laboratory results. The patient developed septic shock, needing intensive care, mechanical ventilation, and renal replacement therapy. CMV viral load was elevated, confirming the diagnosis of CMV-associated septic shock with DIC; the patient had an improved clinical response followed ganciclovir in conjunction with broad-spectrum antibiotics and extensive supportive care, including transfusions of fresh frozen plasma, cryoprecipitate, platelets, packed red blood cells, and vitamin K. Three weeks of targeted antiviral therapy and comprehensive supportive care allowed the patient's renal function, coagulation parameters, and clinical status to improve such that the patient could be safely discharged. This case highlights the need for early identification and very aggressive management of CMV infections in immunosuppressed patients to prevent life-threatening complications such as septic shock and DIC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.